Organogenesis Holdings Inc. (ORGO) intrinsic value & 10-year financials
Organogenesis Holdings Inc. (ORGO) has a Graham intrinsic value of $0.77 per share. At $1.00 on Oct 17, 2026, the stock trades 30% above that value. Over the last 10 fiscal years revenue grew 16.9% a year to $564.2M, with an average return on invested capital of -7.2%.
- Graham intrinsic value
- $0.77
- Share price (Oct 17, 2026)
- $1.00
- Price vs Graham value
- 30% above
- Market cap
- $130.2M
- Revenue (FY2025)
- $564.2M
- Revenue growth (10-yr CAGR)
- 16.9%
- ROIC (10-yr avg)
- -7.2%
- Free cash flow (FY2025)
- -$24.5M
ORGO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $564.2M | $37.0M | $0.15 | -$24.5M | 7.9% | 17.8% |
| FY2024 | $482.0M | $861.0K | -$0.01 | $4.2M | -0.3% | -0.3% |
| FY2023 | $433.1M | $4.9M | $0.04 | $6.6M | 2.9% | 2.3% |
| FY2022 | $450.9M | $15.5M | $0.12 | -$9.0M | 4.9% | 6.5% |
| FY2021 | $468.1M | $94.9M | $0.71 | $30.8M | 15.6% | 37.2% |
| FY2020 | $338.3M | $17.9M | $0.16 | -$14.3M | 8.1% | 28.3% |
| FY2019 | $261.0M | -$40.5M | -$0.44 | -$39.5M | -11.3% | -65.4% |
| FY2018 | $193.4M | -$64.8M | -$0.94 | -$62.6M | -26.7% | -90.4% |
| FY2017 | $198.5M | -$2.1M | — | -$3.0M | -2.3% | -4.0% |
| FY2016 | $138.7M | -$208.7K | — | -$1.9M | -0.2% | -4.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Organogenesis Holdings Inc. is a consistent compounder, expanding top-line revenue at 16.9% annually over the past decade.
Organogenesis Holdings Inc. has historically struggled to out-earn its cost of capital, averaging just -7.2% ROIC.
Organogenesis Holdings Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Organogenesis Holdings Inc. is modeled at -1.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.77 per share.